Every material Form 8-K CTS filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CTS Corporation furnished an October 2026 investor presentation under Regulation FD. It shows third-quarter 2026 net sales of $149.6 million, up from $143.0 million a year earlier, and GAAP diluted EPS of $0.61 versus $0.46. The deck also gives updated fiscal 2026 guidance of $580 million to $590 million in revenue and $2.78 to $2.88 in adjusted diluted EPS, with the Millar acquisition included.
Q3 2026 net sales were $149.6 million, compared with $143.0 million in Q3 2025.
Q3 2026 net earnings were $17.8 million, or $0.61 per diluted share, compared with $13.7 million, or $0.46, a year earlier; adjusted diluted EPS was $0.77 versus $0.60.
Updated FY 2026 guidance: revenue of $580 million to $590 million and adjusted diluted EPS of $2.78 to $2.88, including the expected impact of the Millar acquisition.
Q3 2026 results include a $12.5 million pretax insurance recovery, which the company excludes from adjusted figures.
CTS reported third-quarter 2026 sales of $149.6 million, up 5% from a year earlier, and diluted EPS of $0.61 versus $0.46. It raised its 2026 guidance, lifting the sales range to $580-$590 million from $565-$585 million and the adjusted diluted EPS range to $2.78-$2.88 from $2.55-$2.70. Reported third-quarter results include a $12.5 million insurance recovery that the company excludes from its adjusted figures.
Q3 2026 sales were $149.6 million, up 5%; diluted EPS was $0.61 versus $0.46, and adjusted diluted EPS was $0.77 versus $0.60.
2026 sales guidance raised to $580-$590 million from $565-$585 million.
2026 adjusted diluted EPS guidance raised to $2.78-$2.88 from $2.55-$2.70.
Q3 2026 results include a $12.5 million insurance recovery, which the company excludes from adjusted EBITDA and adjusted EPS.
CTS reported second-quarter 2026 sales of $144.8 million, up 7% from a year earlier, with net earnings of $19.2 million and diluted EPS of $0.66, compared with $18.5 million and $0.62 in the second quarter of 2025. The company raised its 2026 guidance, lifting its sales outlook to $565 million to $585 million and its adjusted diluted EPS outlook to $2.55 to $2.70. Transportation sales declined 2%, while sales to diversified end markets rose 15%.
Sales were $144.8 million, up 7%; diversified end-market sales rose 15% and transportation sales fell 2%.
Net earnings were $19.2 million, or $0.66 per diluted share, versus $18.5 million, or $0.62, a year earlier.
Adjusted diluted EPS was $0.74, up from $0.57; adjusted EBITDA margin was 25.4%, up from 23.0%.
2026 guidance raised: sales to $565 million to $585 million (from $560 million to $580 million); adjusted diluted EPS to $2.55 to $2.70 (from $2.35 to $2.45).
CTS Corporation said its President and CEO, Kieran O'Sullivan, will step down effective July 6, 2026, and remain on the Board as Executive Chairman. The Board appointed Chief Operating Officer Pratik Trivedi as President and CEO on the same date, and expanded the Board from eight to nine directors.
Kieran O'Sullivan steps down as CEO effective July 6, 2026, and becomes Executive Chairman with a $625,000 base salary.
Pratik Trivedi, 47, becomes President and CEO with a $675,000 base salary and a 100% target annual cash incentive.
Trivedi's new long-term incentive award has a value of $2,150,000, split 60% performance-based and 40% service-based restricted stock units.
O'Sullivan will receive no new long-term incentive award; the Board increases from eight to nine directors.
CTS reported first-quarter 2026 sales of $139.2 million, up 11% from a year earlier, with net income of $17.2 million and diluted EPS of $0.59 versus $0.44. The company narrowed its 2026 guidance, raising the low end of its sales range to $560 million-$580 million and of its adjusted diluted EPS range to $2.35-$2.45, which points to stronger expected results for shareholders.
Q1 2026 sales $139.2 million, up 11% year over year; diversified end-market sales up 18%, transportation up 3%
Diluted EPS $0.59 versus $0.44 a year earlier; adjusted diluted EPS $0.62 versus $0.44
2026 sales guidance narrowed to $560 million-$580 million from $550 million-$580 million
2026 adjusted diluted EPS guidance narrowed to $2.35-$2.45 from $2.30-$2.45, assuming current market conditions continue
CTS reported fourth-quarter and full-year 2025 results on February 10, 2026, with sales and profit both higher than in 2024. The company also gave 2026 guidance of $550 million to $580 million in sales and adjusted diluted EPS of $2.30 to $2.45, which gives shareholders a current outlook for the year ahead.
Q4 2025 sales were $137 million, up 9% year over year; diversified end markets rose 16% while transportation fell 1%
Q4 2025 diluted EPS was $0.67 versus $0.38; adjusted diluted EPS was $0.62 versus $0.50
Full-year 2025 sales were $541 million, up 5%; diluted EPS was $2.19 versus $1.80, and adjusted diluted EPS was $2.23 versus $2.12
2026 guidance: sales of $550 million to $580 million and adjusted diluted EPS of $2.30 to $2.45
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CTS filing is on SEC EDGAR ↗. 8-K briefs of other companies →